Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Screening for Pancreatic Cancer in Patients with an Inherited BRCA1, BRCA2, PALB2 or ATM Mutation
Glossary on
off
Printer Friendly Page Screening for Pancreatic Cancer in Patients with an Inherited BRCA1, BRCA2, PALB2 or ATM Mutation

Screening for Pancreatic Cancer in Patients with an Inherited BRCA1, BRCA2, PALB2 or ATM Mutation

Clinicaltrials.gov identifier:
NCT02478892


Pancreatic cancer screening for people at high risk and with an inherited BRCA1, BRCA2, ATM, or PALB2 mutation

Study Contact Information:

   

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with an Inherited Genetic Risk Due to a BRCA1, BRCA2, PALB2 or ATM Mutation

About this Study

NOTE: This Study is no longer recruiting patients. 

Improved screening for pancreatic cancer in high-risk groups, such as people with an inherited , , , or mutation, may help find cancer early and improve survival rates. People enrolled in this study will undergo screening using endoscopic or of the abdomen.

 

 

This Study is Open To:

NOTE: This Study is no longer recruiting patients.

This Study is Not Open To:

NOTE: This Study is no longer recruiting patients.